Literature DB >> 1885793

MR imaging of partial anomalous pulmonary venous connections.

T M Vesely1, P R Julsrud, J J Brown, D J Hagler.   

Abstract

Magnetic resonance imaging was performed on 11 patients with partial anomalous pulmonary venous connections (PAPVC). Ten of these patients also had echocardiographic examinations, eight of which included color-flow Doppler studies. The diagnosis of PAPVC was confirmed in each of these patients by surgery or angiography. Fourteen anomalous pulmonary venous connections were identified, 10 involving the right upper lobe pulmonary vein and 4 involving the left upper lobe pulmonary vein. This retrospective review demonstrated that all 14 anomalous venous connections were correctly identified by MR imaging, whereas only 8 of 13 (62%) were identified by echocardiography. With MR, 89% of all the pulmonary veins and 93% of the anomalous pulmonary veins were visualized on axial images, while 41% of all pulmonary veins and 71% of anomalous veins were seen on coronal MR images. There were five atrial septal defects (ASDs), four of the sinus venous type and one of the septum secundum type. All five ASDs were correctly identified with MR imaging; three of four ASDs were identified with echocardiography. We conclude that MR imaging provides an accurate noninvasive method of depicting the anatomic abnormalities associated with PAPVC.

Entities:  

Mesh:

Year:  1991        PMID: 1885793     DOI: 10.1097/00004728-199109000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

Review 1.  MR imaging of congenital heart diseases in adolescents and adults.

Authors:  Y H Choe; I S Kang; S W Park; H J Lee
Journal:  Korean J Radiol       Date:  2001 Jul-Sep       Impact factor: 3.500

2.  Partial anomalous pulmonary venous return to the azygos vein: an unusual case.

Authors:  Chantale Lapierre; Ana Siles; Jean-Luc Bigras
Journal:  Pediatr Cardiol       Date:  2010-02-27       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.